Predictors of Intravenous Ketamine Response in TRD

Clinical trial NCT05625555 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05625555
Sponsor: Abraham Nunes
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Treatment Resistant Depression Major Depressive Disorder Bipolar Disorder

Start date: 2024-01-19
Primary completion: 2026-07-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.